School of Pharmaceutical Sciences, EPGL, University of Geneva, University of Lausanne, Geneva, Switzerland.
PLoS One. 2013 May 21;8(5):e64006. doi: 10.1371/journal.pone.0064006. Print 2013.
Natural products (NPs) are an attractive source of chemical diversity for small-molecule drug discovery. Several challenges nevertheless persist with respect to NP discovery, including the time and effort required for bioassay-guided isolation of bioactive NPs, and the limited biomedical relevance to date of in vitro bioassays used in this context. With regard to bioassays, zebrafish have recently emerged as an effective model system for chemical biology, allowing in vivo high-content screens that are compatible with microgram amounts of compound. For the deconvolution of the complex extracts into their individual constituents, recent progress has been achieved on several fronts as analytical techniques now enable the rapid microfractionation of extracts, and microflow NMR methods have developed to the point of allowing the identification of microgram amounts of NPs. Here we combine advanced analytical methods with high-content screening in zebrafish to create an integrated platform for microgram-scale, in vivo NP discovery. We use this platform for the bioassay-guided fractionation of an East African medicinal plant, Rhynchosia viscosa, resulting in the identification of both known and novel isoflavone derivatives with anti-angiogenic and anti-inflammatory activity. Quantitative microflow NMR is used both to determine the structure of bioactive compounds and to quantify them for direct dose-response experiments at the microgram scale. The key advantages of this approach are (1) the microgram scale at which both biological and analytical experiments can be performed, (2) the speed and the rationality of the bioassay-guided fractionation - generic for NP extracts of diverse origin - that requires only limited sample-specific optimization and (3) the use of microflow NMR for quantification, enabling the identification and dose-response experiments with only tens of micrograms of each compound. This study demonstrates that a complete in vivo bioassay-guided fractionation can be performed with only 20 mg of NP extract within a few days.
天然产物 (NPs) 是小分子药物发现中具有吸引力的化学多样性来源。然而,在 NP 发现方面仍然存在一些挑战,包括生物活性 NPs 的生物测定指导分离所需的时间和精力,以及迄今为止在这种情况下使用的体外生物测定与生物医学相关性有限。就生物测定而言,斑马鱼最近已成为化学生物学的有效模型系统,允许进行体内高通量筛选,同时兼容微克数量的化合物。为了将复杂提取物分解为其各个成分,在分析技术现在能够快速微分离提取物的情况下,在几个方面取得了进展,并且微流 NMR 方法已经发展到可以识别微克数量的 NPs 的程度。在这里,我们将先进的分析方法与斑马鱼中的高通量筛选相结合,创建了一个用于微克规模体内 NP 发现的集成平台。我们使用该平台对东非药用植物 Rhynchosia viscosa 进行生物测定指导的分馏,从而鉴定出具有抗血管生成和抗炎活性的已知和新型异黄酮衍生物。定量微流 NMR 既用于确定生物活性化合物的结构,又用于在微克规模上进行直接剂量反应实验进行定量。这种方法的主要优势在于:(1) 可以进行生物和分析实验的微克规模,(2) 生物测定指导的分馏速度快且合理 - 适用于不同来源的 NP 提取物 - 仅需要有限的样品特异性优化,以及 (3) 微流 NMR 用于定量,仅需数十微克每种化合物即可进行鉴定和剂量反应实验。这项研究表明,仅用 20 毫克 NP 提取物在几天内即可完成完整的体内生物测定指导的分馏。